000			01710nam a22002537a 4500
999			_c11552 _d11552
003			MED20180016
005			20240720153132.0
008			191010b xxu||||| |||| 00| 0 eng d
040			_cFEU-NRMF MEDICAL LIBRARY
050			_aMED20180016
100			_aMendez, Elbert DG., MD. _eprincipal investigator
245			_aReal-world effectiveness of angiotensin receptor blokers (ARB) versus non-ARB agents in blood pressure control / _cElbert DG. Mendez and Jeru Faisal Usman.
260			_aFairview, Quezon City _bDepartment of Medicine, FEU-NRMF, _c2018
300			_a12 pages. _c(in folder) + _eCD (soft copy)
336			_2rdacontent _atext
337			_2rdamedia _aunmediated
338			_2rdacarrier _avolume
500			_aIncludes CD (soft copy).
504			_aIncludes appendices and bibliographical references.
520			_aABSTRACT: Several guidelines for management of hypertension had been organized and designed in the hope of controlling blood pressure and avert cardiovascular events. However, even with adherence to these guidelines, majority of hypertensive population remains to be uncontrolled. Clinical trials generally obtain data under a tightly controlled setting, and populations often donot present those seen in reallife practice. Angiotensin-receptor Blokers (ARB)are one of the most widely used antihypertensive agent and, together with calcium channel blockers, are the most widely used antihypertensive agents. The question now is whether ARBs are as effective when it comes to control of hypertension in a real-world practice just as what the guidelines have started.
521			_aRESDM
700			_aUsman, Jeru Faisal, MD. _esupervising investigator
942			_2lcc _cRE